Itayem Deeyar A, Sladen Douglas, Driscoll Colin L, Neff Brian A, Beatty Charles W, Carlson Matthew L
Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.
Otol Neurotol. 2017 Dec;38(10):e445-e450. doi: 10.1097/MAO.0000000000001615.
To report a unique clinical entity "cochlear implant associated labyrinthitis," characterized by a distinct constellation of clinical symptoms and pattern of electrode impedance fluctuations.
Retrospective chart review.
All patients that underwent cochlear implantation between January 2014 and December 2016 were retrospectively reviewed. All subjects with acute onset dizziness, device performance decline, and characteristic erratic pattern of electrode impedances occurring after an asymptotic postoperative interval were identified and reported.
Five patients with the above criteria were identified, representing 1.4% of all implant surgeries performed during this time. The median age at time of implantation was 71 years, and the median time interval between implantation and onset of symptoms was 126 days. All patients exhibited acute onset dizziness, subjective performance deterioration, erratic impedance pattern, and two experienced worsening tinnitus. Two of five patients underwent subsequent CT imaging, where good electrode placement was confirmed without cochlear ossification. Two of five patients received oral prednisone therapy. All patients reported a subjective improvement in symptoms and stabilization of electrode impedances. Three patients subsequently received vestibular testing, where significantly reduced peripheral vestibular function was identified.
We describe a unique clinical entity, "cochlear implant associated labyrinthitis," characterized by a distinct constellation of clinical symptoms and corresponding electrode impedance anomalies. The exact cause for this event remains unknown, but may be related to viral illness, delayed foreign body reaction to the electrode, or a reaction to electrical stimulation. Future studies characterizing this unique clinical entity are needed to further elucidate cause and optimal management.
报告一种独特的临床病症“人工耳蜗相关迷路炎”,其特征为一系列独特的临床症状和电极阻抗波动模式。
回顾性病历审查。
对2014年1月至2016年12月期间接受人工耳蜗植入的所有患者进行回顾性审查。识别并报告所有术后经过一段无症状期后出现急性头晕、设备性能下降以及电极阻抗特征性不稳定模式的受试者。
确定了5例符合上述标准的患者,占该时间段内所有植入手术的1.4%。植入时的中位年龄为71岁,植入与症状发作之间的中位时间间隔为126天。所有患者均表现出急性头晕、主观性能恶化、阻抗模式不稳定,2例患者耳鸣加重。5例患者中有2例随后接受了CT成像,确认电极放置良好且无耳蜗骨化。5例患者中有2例接受了口服泼尼松治疗。所有患者均报告症状主观改善且电极阻抗稳定。3例患者随后接受了前庭测试,结果显示外周前庭功能显著降低。
我们描述了一种独特的临床病症“人工耳蜗相关迷路炎”,其特征为一系列独特的临床症状及相应的电极阻抗异常。该事件的确切原因尚不清楚,但可能与病毒感染、对电极的延迟异物反应或对电刺激的反应有关。需要进一步开展研究以明确这一独特临床病症的特征,从而进一步阐明病因及最佳治疗方法。